---
title: "DynamX sirolimus-eluting bioadaptor system gains US FDA breakthrough designation"
date: "2024-06-19T23:20:41.000Z"
publishedDate: "19 juin 2024"
summary: "Elixir Medical has announced that its novel bioadaptive implant, the DynamX sirolimus-eluting coronary bioadaptor system, has been granted breakthrough device designation by the US Food and Drug Administration (FDA). The breakthrough designation is for an indication to improve coronary luminal diameter, restore haemodynamic modulation, and reduce plaque progression in patients with symptomatic ischaemic heart disease [&#8230;] The post DynamX sirolimus-eluting bioadaptor system gains US FDA breakthrough designation appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/dynamx-us-fda-breakthrough-designation/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-06-19-dynamx-sirolimus-eluting-bioadaptor-system-gains-us-fda-breakthrough-designation"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/06/DynamX-expanded-in-vessel-WEB.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/dynamx-us-fda-breakthrough-designation/"
---

![DynamX sirolimus-eluting bioadaptor system gains US FDA breakthrough designation](https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/06/DynamX-expanded-in-vessel-WEB.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/dynamx-us-fda-breakthrough-designation/*

## L’essentiel

Elixir Medical has announced that its novel bioadaptive implant, the DynamX sirolimus-eluting coronary bioadaptor system, has been granted breakthrough device designation by the US Food and Drug Administration (FDA). The breakthrough designation is for an indication to improve coronary luminal diameter, restore haemodynamic modulation, and reduce plaque progression in patients with symptomatic ischaemic heart disease [&#8230;] The post DynamX sirolimus-eluting bioadaptor system gains US FDA breakthrough designation appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/dynamx-us-fda-breakthrough-designation/
